Bernstein Karen 4
4 · Ovid Therapeutics Inc. · Filed Jun 11, 2021
Insider Transaction Report
Form 4
Bernstein Karen
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-06-11+15,000→ 15,000 totalExercise: $4.49Exp: 2031-06-10→ Common Stock (15,000 underlying)
Footnotes (1)
- [F1]The option will vest in full on June 11, 2022 subject to the Reporting Person's continuous service through such vesting date.